See more : Lamprell plc (LAM.L) Income Statement Analysis – Financial Results
Complete financial analysis of Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Guangdong Zhongsheng Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Yunnan Yuntianhua Co., Ltd. (600096.SS) Income Statement Analysis – Financial Results
- CYIOS Corporation (CYIO) Income Statement Analysis – Financial Results
- Tokyo Plast International Limited (TOKYOPLAST.BO) Income Statement Analysis – Financial Results
- Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ) Income Statement Analysis – Financial Results
- Kyoritsu Printing Co., Ltd. (7838.T) Income Statement Analysis – Financial Results
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
About Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. The company was founded in 1979 and is based in Dongguan, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.61B | 2.68B | 2.43B | 1.90B | 2.53B | 2.36B | 1.96B | 1.69B | 1.58B | 1.31B | 1.09B | 886.43M | 750.64M | 640.71M | 551.60M | 484.31M | 404.40M | 326.90M |
| Cost of Revenue | 1.08B | 940.49M | 806.56M | 657.14M | 917.45M | 903.94M | 811.14M | 516.20M | 573.14M | 517.41M | 451.87M | 337.67M | 272.39M | 234.75M | 211.68M | 227.07M | 214.68M | 189.97M |
| Gross Profit | 1.53B | 1.74B | 1.62B | 1.24B | 1.61B | 1.46B | 1.15B | 1.18B | 1.00B | 791.10M | 638.16M | 548.76M | 478.26M | 405.96M | 339.92M | 257.24M | 189.73M | 136.92M |
| Gross Profit Ratio | 58.60% | 64.86% | 66.80% | 65.34% | 63.76% | 61.72% | 58.70% | 69.50% | 63.67% | 60.46% | 58.55% | 61.91% | 63.71% | 63.36% | 61.62% | 53.11% | 46.92% | 41.89% |
| Research & Development | 127.37M | 156.59M | 136.73M | 113.62M | 132.58M | 84.29M | 67.52M | 74.16M | 67.51M | 67.06M | 52.10M | 30.99M | 31.93M | 27.57M | 0.00 | 11.75M | 8.34M | 5.33M |
| General & Administrative | 48.03M | 41.56M | 57.99M | 50.51M | 56.52M | 47.22M | 34.97M | 24.00M | 30.26M | 20.48M | 15.39M | 11.60M | 12.56M | 9.79M | 37.05M | 10.33M | 9.24M | 7.54M |
| Selling & Marketing | 858.36M | 1.00B | 940.74M | 722.29M | 853.75M | 749.82M | 593.68M | 589.61M | 527.61M | 434.84M | 358.21M | 300.64M | 255.44M | 225.92M | 185.21M | 135.86M | 100.53M | 76.10M |
| SG&A | 906.39M | 1.04B | 998.72M | 772.80M | 910.27M | 797.03M | 628.65M | 613.61M | 557.87M | 455.32M | 373.60M | 312.24M | 267.99M | 235.71M | 222.26M | 146.19M | 109.78M | 83.64M |
| Other Expenses | 10.73M | 142.68M | 86.71M | 71.38M | 89.00M | -986.95K | -1.98M | 25.49M | 9.98M | 7.47M | 9.29M | 12.76M | -10.64M | -9.64M | 7.43M | 5.16M | -4.22M | 269.09K |
| Operating Expenses | 1.23B | 1.34B | 1.22B | 957.80M | 1.13B | 940.33M | 692.34M | 747.99M | 684.88M | 567.74M | 456.86M | 373.50M | 326.75M | 279.99M | 227.31M | 169.31M | 128.17M | 97.70M |
| Cost & Expenses | 2.31B | 2.28B | 2.03B | 1.61B | 2.05B | 1.84B | 1.50B | 1.26B | 1.26B | 1.09B | 908.73M | 711.18M | 599.14M | 514.74M | 438.99M | 396.38M | 342.85M | 287.67M |
| Interest Income | 30.61M | 27.63M | 26.08M | 27.03M | 30.86M | 26.86M | 4.66M | 2.31M | 3.45M | 4.49M | 19.19M | 27.69M | 19.19M | 19.41M | 0.00 | 194.99K | 343.82K | -0.09 |
| Interest Expense | 46.91M | 73.36M | 73.81M | 37.20M | 48.22M | 34.05M | 7.69M | 5.99M | 8.78M | 4.35M | 657.82K | 433.21K | 427.46K | 690.30K | 3.96M | 6.81M | 4.73M | 3.28M |
| Depreciation & Amortization | 121.15M | 99.92M | 95.47M | 97.53M | 98.87M | 78.52M | 67.22M | 65.39M | 63.24M | 50.03M | 30.31M | 25.90M | 19.75M | 15.32M | 13.73M | 12.61M | 10.96M | 10.79M |
| EBITDA | 451.72M | 542.79M | 479.31M | -207.02M | 525.38M | 611.48M | 571.83M | 556.14M | 414.86M | 303.27M | 250.35M | 239.21M | 195.36M | 169.16M | 132.44M | 104.87M | 67.55M | 49.75M |
| EBITDA Ratio | 17.30% | 20.20% | 22.20% | 25.67% | 24.38% | 26.68% | 28.36% | 33.26% | 26.29% | 23.92% | 23.03% | 27.25% | 26.43% | 26.47% | 23.15% | 21.86% | 16.96% | 15.22% |
| Operating Income | 346.21M | 374.26M | 443.32M | 388.01M | 518.91M | 500.95M | 493.70M | 458.30M | 332.72M | 240.80M | 209.30M | 200.25M | 168.78M | 144.23M | 108.66M | 80.32M | 56.65M | 36.40M |
| Operating Income Ratio | 13.26% | 13.99% | 18.25% | 20.47% | 20.50% | 21.21% | 25.13% | 27.08% | 21.09% | 18.40% | 19.20% | 22.59% | 22.48% | 22.51% | 19.70% | 16.58% | 14.01% | 11.14% |
| Total Other Income/Expenses | -62.55M | -5.59M | -58.68M | -733.28M | -95.11M | -986.95K | -1.98M | 25.09M | 9.18M | 7.46M | 8.68M | 12.56M | 6.38M | 27.55M | 2.12M | 5.13M | -4.79M | 75.49K |
| Income Before Tax | 283.66M | 368.30M | 309.48M | -345.27M | 378.88M | 499.96M | 491.72M | 483.39M | 341.90M | 248.26M | 217.98M | 212.81M | 175.15M | 153.15M | 114.75M | 85.45M | 51.86M | 36.48M |
| Income Before Tax Ratio | 10.87% | 13.76% | 12.74% | -18.21% | 14.97% | 21.17% | 25.03% | 28.56% | 21.67% | 18.97% | 20.00% | 24.01% | 23.33% | 23.90% | 20.80% | 17.64% | 12.82% | 11.16% |
| Income Tax Expense | 33.76M | 52.95M | 34.81M | 89.16M | 59.10M | 69.46M | 68.72M | 62.90M | 46.27M | 32.28M | 30.61M | 31.30M | 24.61M | 21.64M | 14.39M | 11.07M | 6.72M | 1.88M |
| Net Income | 263.27M | 322.05M | 277.63M | -434.43M | 317.73M | 435.65M | 420.12M | 414.37M | 296.71M | 224.56M | 187.70M | 181.51M | 150.54M | 131.51M | 100.35M | 74.38M | 42.27M | 31.88M |
| Net Income Ratio | 10.08% | 12.03% | 11.43% | -22.92% | 12.55% | 18.45% | 21.39% | 24.48% | 18.81% | 17.16% | 17.22% | 20.48% | 20.05% | 20.53% | 18.19% | 15.36% | 10.45% | 9.75% |
| EPS | 0.32 | 0.40 | 0.35 | -0.54 | 0.40 | 0.54 | 0.52 | 0.55 | 0.41 | 0.31 | 0.26 | 0.25 | 0.21 | 0.18 | 0.19 | 0.14 | 0.08 | 0.11 |
| EPS Diluted | 0.32 | 0.40 | 0.35 | -0.54 | 0.40 | 0.53 | 0.52 | 0.54 | 0.40 | 0.31 | 0.26 | 0.25 | 0.21 | 0.18 | 0.19 | 0.14 | 0.08 | 0.11 |
| Weighted Avg Shares Out | 822.73M | 805.13M | 797.43M | 803.36M | 803.36M | 806.76M | 807.93M | 753.40M | 723.69M | 724.39M | 721.93M | 726.05M | 716.85M | 720.60M | 537.61M | 539.88M | 543.42M | 298.90M |
| Weighted Avg Shares Out (Dil) | 822.73M | 805.13M | 797.43M | 803.36M | 803.36M | 821.98M | 807.93M | 767.35M | 741.79M | 724.39M | 721.93M | 726.05M | 716.85M | 720.60M | 537.61M | 539.88M | 543.42M | 298.90M |
No news found for: 002317.SZ
Source: https://incomestatements.info
Category: Stock Reports